Previous studies showed that T cells isolated and activated ex vivo from RA patients treated with MTX have a diminished capacity to produce IFNγ, IL-4, IL-3, TNF, and granulocyte-macrophage colony-stimulating factor (58, 59). This evidence concerns the gene IL4 and rheumatoid arthritis.